Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.  

Martin Lepage uses using functional magnetic resonance imaging (fMRI) to study memory deficits in patients with schizophrenia.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Jocelyne Lahoud is Administrative Director, Research Centre, Douglas Institute

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.

Hani Iskandar has been involved in clinical research projects in the fields of schizophrenia, mood disorders and pharmacology.